9 November, 2025 - Neomatrix is at SITC 2025 with two selected abstracts

Fabio Palombo , our CSO and Emily Young , director at 4Basebio will be presenting Neomatrix technology for developing personalized cancer vaccines, based on synthetic DNA and a novel heterologous prime/boost modality which includes next generation, targeted LNP.

Visit our poster and attend Emily's presentation to learn more.

9 November, 2025 - Neomatrix is at SITC 2025 with two selected abstracts

Seal of Excellence - EU Quality Label

Policy

Contact